Endpoints News 2025-12-13 Eli Lilly’s triple-G obesity readout; The latest Endpoints 100 results; Public biotechs cash in; and more
Endpoints News 2025-12-12 340B sales grew 23% last year, and court battle over pilot program intensifies
Endpoints News 2025-12-12 Covid vaccine deaths review sent to top of FDA, but with far less certain conclusions, sources say
Endpoints News 2025-12-12 CHMP calls to reject Anavex's Alzheimer’s pill over impurities, side effects and weak efficacy
Endpoints News 2025-12-12 #SABCS25: Celcuity further details Phase 3 win; Relay’s PI3Kα inhibitor’s consistent performance; and more
Endpoints News 2025-12-12 Innovent’s obesity drug data in adolescents; Everest gets rights to PCSK9 inhibitor
Endpoints News 2025-12-12 FDA broadens label for Amgen's Uplizna as it enters rare disease competition
Endpoints News 2025-12-11 Top Trump lawyer calls on SCOTUS to reverse 'skinny' generic drug label decision